LanzaTech & DTU to Open Biofoundry to Turn Carbon Emissions Into High-Value Products

Why It Matters

The biofoundry closes a critical technology gap, enabling faster, lower‑risk development of climate‑neutral bioproducts and positioning Europe as a leader in the emerging circular bioeconomy.

Key Takeaways

• LanzaTech and DTU launch AI‑driven C1 biofoundry in Denmark.
• Biofoundry will accelerate strain design for fuels, chemicals, proteins.
• Partnership bridges US synthetic biology expertise with European research infrastructure.
• High‑throughput, AI workflow reduces development risk and speeds commercialization.

Pulse Analysis

Carbon emissions are increasingly being reframed as a feedstock for high‑value bioproducts, a shift driven by both regulatory pressure and investor appetite for sustainable solutions. LanzaTech, which went public via a SPAC in 2022, has spent a decade perfecting gas‑fermentation platforms that turn waste gases into ethanol, sustainable aviation fuel and even protein for food applications. By anchoring its next‑generation C1 biofoundry at DTU’s Bright hub, the company taps into Europe’s deep research talent pool and state‑of‑the‑art laboratory infrastructure, creating a transatlantic bridge that could accelerate the scale‑up of circular bioeconomy technologies.

The biofoundry’s core advantage lies in its AI‑enhanced, high‑throughput workflow. Automated design cycles can generate and test thousands of microbial variants simultaneously, dramatically shortening the time from lab concept to pilot production. Integrated AI models ingest screening data to predict optimal genetic edits, allowing researchers to “fail fast” and iterate more efficiently. This capability not only speeds LanzaTech’s own pipeline for sustainable fuels and biochemicals but also offers a shared platform for academic and industry partners across Europe, fostering collaborative innovation while mitigating the high R&D costs traditionally associated with non‑model anaerobic microbes.

Globally, gas fermentation is gaining momentum, with defense grants, corporate pilots and start‑ups racing to commercialise protein‑from‑air technologies. The U.S. Department of Defense’s recent $9 million grant to Biosphere and the Gates Foundation‑backed Acetate Consortium illustrate the strategic importance of this sector. LanzaTech’s partnership with DTU positions it to capture a growing share of a market projected to reach tens of billions of dollars by the early 2030s, as airlines, consumer goods firms and food producers seek carbon‑neutral inputs. The collaboration signals a broader industry trend: leveraging synthetic biology and AI to transform waste carbon into profitable, climate‑friendly products.